BEIJING( 14 (Xinhua) — Giroud’s experimental antiviral drug remdesivir can prevent infection with MERS in monkeys and reduce the severity of symptoms, according to a study published Thursday in the Proceedings of the National Academy of Sciences.
Since MERS virus and new coronavirus belong to the same family of viruses, this study offers new hope that Redcivir can effectively prevent and treat the new coronavirus.
However, Redciewe has previously been shown to have a protective effect on monkeys infected with the Ebola virus, but this effect has not been transferred to humans.
“It’s not successful on the Ebola virus, but there are some indications that it may have been successful on the coronavirus,” Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), said in a recent interview. “
NIAID scientists tested Redcivir in some monkeys 24 hours and 12 hours before infection and compared them to untreated monkeys in the control group. Six days later, all the untreated animals became ill.
In monkeys treated with Ridsiewe before infection, the drug appeared to have a disease-prevention effect. The monkeys in this group showed no signs of infection, and their levels of the virus in their lungs decreased significantly, with no lung damage.
Monkeys treated after infection were also better than the control group. The researchers found that their condition was less severe, with lower levels of the virus in the lungs and less severe lung damage.
Although many of the drugs that succeed in monkeys have failed in humans. But the researchers say their findings raise hopes for ongoing research in China and compassion for the use of the drug in seriously ill patients.